BFBIO responds to Eterna price misleading claims

MG News | January 14, 2025 at 12:00 PM GMT+05:00

0:00

January 14, 2025 (MLN): While responding to investor's concern regarding a social media post, the management of BF Biosciences Limited (PSX: BFBIO) clarified that Eterna is not a new product.

The company addressed concerns over the inaccurate comparative prices mentioned in the story, the company's filing on PSX revealed today.

The product has been available in the market since May 2023.

The company clarified that the competitive prices mentioned in the news article are incorrect.

Copyright Mettis Link News

Related News

Weekly Market Roundup

First National Equities Limited expands into real estate and infrastructure

Image REIT IPO book-building concludes, strike price set at Rs10.01

Name	Price/Vol	%Chg/NChg
KSE100	154,439.68 241.10M	-1.09% -1701.56
ALLSHR	94,668.16 984.91M	-0.80% -765.63
KSE30	47,119.91 93.25M	-1.26% -600.63
KMI30	226,125.72 147.15M	-1.17% -2674.34
KMIALLSHR	63,569.05 456.03M	-0.92% -592.28
BKTi	41,622.83 56.72M	-1.28% -538.80
OGTi	31,488.79 10.15M	-1.08% -344.95

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	116,850.00	117,320.00 114,850.00	1920.00 1.67%
BRENT CRUDE	66.88	68.17 65.71	0.51 0.77%
RICHARDS BAY COAL MONTHLY	84.00	84.00 84.00	-1.90 -2.21%
ROTTERDAM COAL MONTHLY	93.00	93.25 92.75	0.00 0.00%
USD RBD PALM OLEIN	1,106.50	1,106.50 1,106.50	0.00 0.00%
CRUDE OIL - WTI	62.60	63.98 61.69	0.23 0.37%
SUGAR #11 WORLD	15.81	15.87 15.67	-0.01 -0.06%